BTLA-mediated regulation of neuroimmune responses enhances recovery after intracerebral hemorrhage.

J Neuroinflammation · 2026 · PMC12910923 · PMID 41578304

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although anti-BTLA agonist antibody treatment showed a tendency to reduce astrocyte activity (GFAP-positive cells, t = 1.681, P = 0.1236) and neurodegeneration (FJB-positive cells, t = 1.394, P = 0.1936) in the perihematomal regions on day 3 after ICH, these effects did not reach statistical significance (Fig. 4 A and C).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.